Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q2 2017 (← Previous) (Next →)

Filing Date: Aug 14, 2017

Total Value: $2.142B (100.0% shares, 0.0% debt)

Holdings (38)

CLOVIS ONCOLOGY INC 14.6%
Value $312M Shares 3,329,581 Est. Cost $54.10 Unrealized
ABIOMED INC 13.1%
Value $280M Shares 1,951,284 Est. Cost $32.04 Unrealized
UTHR UNITED THERAPEUTICS CORP DEL 11.3%
Value $242M Shares 1,867,315 Est. Cost $88.34 Unrealized +41.2%
BMRN BIOMARIN PHARMACEUTICAL INC 10.1%
Value $217M Shares 2,384,719 Est. Cost $79.29 Unrealized +14.7%
ALEXION PHARMACEUTICALS INC 5.9%
Value $125M Shares 1,030,942 Est. Cost $120.21 Unrealized
INSM INSMED INC 4.5%
Value $96.47M Shares 5,621,816 Est. Cost $14.61 Unrealized +16.9%
EPIZYME INC 4.0%
Value $86.04M Shares 5,698,296 Est. Cost $14.85 Unrealized
SAGE THERAPEUTICS INC 3.8%
Value $82.27M Shares 1,033,025 Est. Cost $42.59 Unrealized
FOLD AMICUS THERAPEUTICS INC 3.7%
Value $79.96M Shares 7,940,788 Est. Cost $6.23 Unrealized +29.1%
WRIGHT MED GROUP N V 3.4%
Value $73.57M Shares 2,676,393 Est. Cost $23.44 Unrealized
VNDA VANDA PHARMACEUTICALS INC 3.2%
Value $68.51M Shares 4,203,270 Est. Cost $8.70 Unrealized +65.6%
AMAG PHARMACEUTICALS INC 2.9%
Value $61.54M Shares 3,344,620 Est. Cost $29.94 Unrealized
PRTA PROTHENA CORP PLC 2.7%
Value $58.12M Shares 1,073,955 Est. Cost $32.41 Unrealized +64.4%
ACAD ACADIA PHARMACEUTICALS INC 2.1%
Value $45M Shares 1,613,330 Est. Cost $29.78 Unrealized +0.1%
CELGENE CORP 1.8%
Value $38.34M Shares 295,240 Est. Cost $97.51 Unrealized
STAA STAAR SURGICAL CO 1.8%
Value $38.11M Shares 3,529,070 Est. Cost $8.00 Unrealized +22.2%
ALGN ALIGN TECHNOLOGY INC 1.6%
Value $33.49M Shares 223,107 Est. Cost $94.04 Unrealized +44.2%
KARYOPHARM THERAPEUTICS INC 1.5%
Value $31.38M Shares 3,467,575 Est. Cost $19.70 Unrealized
MOMENTA PHARMACEUTICALS INC 1.4%
Value $30.21M Shares 1,787,576 Est. Cost $14.13 Unrealized
IMMUNOMEDICS INC 1.2%
Value $26.58M Shares 3,010,466 Est. Cost $8.83 Unrealized
AIMMUNE THERAPEUTICS INC 1.2%
Value $26.52M Shares 1,289,719 Est. Cost $22.25 Unrealized
GILD GILEAD SCIENCES INC 1.2%
Value $24.89M Shares 351,600 Est. Cost $62.02 Unrealized -22.1%
SHIRE PLC 1.0%
Value $21.52M Shares 130,200 Est. Cost $219.26 Unrealized
EXAS EXACT SCIENCES CORP 0.7%
Value $15.32M Shares 433,076 Est. Cost $13.61 Unrealized +126.7%
RIGEL PHARMACEUTICALS INC 0.5%
Value $10.52M Shares 3,855,024 Est. Cost $3.39 Unrealized
ALIMERA SCIENCES INC 0.2%
Value $4.189M Shares 3,013,793 Est. Cost $4.88 Unrealized
SUNESIS PHARMACEUTICALS INC 0.1%
Value $3.139M Shares 1,162,473 Est. Cost $4.37 Unrealized
ACELRX PHARMACEUTICALS INC 0.1%
Value $2.22M Shares 1,032,715 Est. Cost $5.54 Unrealized
DICERNA PHARMACEUTICALS INC 0.1%
Value $1.588M Shares 500,913 Est. Cost $5.39 Unrealized
CEMPRA INC 0.1%
Value $1.565M Shares 340,320 Est. Cost $22.71 Unrealized
CYTK CYTOKINETICS INC 0.1%
Value $1.497M Shares 123,686 Est. Cost $6.71 Unrealized +107.0%
IDERA PHARMACEUTICALS INC 0.0%
Value $1.06M Shares 616,355 Est. Cost $3.70 Unrealized
TREVENA INC 0.0%
Value $785K Shares 341,300 Est. Cost $2.30 Unrealized
SOPHIRIS BIO INC 0.0%
Value $543K Shares 247,000 Est. Cost $2.60 Unrealized
HISTOGENICS CORP 0.0%
Value $542K Shares 302,922 Est. Cost $11.00 Unrealized
ZOGENIX INC 0.0%
Value $428K Shares 29,500 Est. Cost $13.36 Unrealized
ALCOBRA LTD 0.0%
Value $306K Shares 272,788 Est. Cost $5.98 Unrealized
SOLENO THERAPEUTICS INC 0.0%
Value $212K Shares 423,738 Est. Cost $0.50 Unrealized